| Identification | Back Directory | [Name]
L-Glutamic acid, L-phenylalanyl-L-asparaginyl-L-asparaginyl-L-phenylalanyl-L-threonyl-L-valyl-L-seryl-L-phenylalanyl-L-tryptophyl-L-leucyl-L-arginyl-L-valyl-L-prolyl-L-lysyl-L-valyl-L-seryl-L-alanyl-L-seryl-L-histidyl-L-leucyl- | [CAS]
126779-14-4 | [Synonyms]
L-Glutamic acid, L-phenylalanyl-L-asparaginyl-L-asparaginyl-L-phenylalanyl-L-threonyl-L-valyl-L-seryl-L-phenylalanyl-L-tryptophyl-L-leucyl-L-arginyl-L-valyl-L-prolyl-L-lysyl-L-valyl-L-seryl-L-alanyl-L-seryl-L-histidyl-L-leucyl- | [Molecular Formula]
C117H172N30O30 | [MOL File]
126779-14-4.mol | [Molecular Weight]
2478.8 |
| Hazard Information | Back Directory | [Uses]
Influenza A NP (383-391) (HLA-B27) is a peptide sequence derived from tetanus toxin. Influenza A NP (383-391) (HLA-B27) is a broadly immunogenic CD4+ T helper cell epitope that enhances CD8+ cytotoxic T lymphocyte (CTL) responses. Influenza A NP (383-391) (HLA-B27) can be used in breast cancer research[1]. | [References]
[1] Y Xie, et al. "Potent CD4+ T-cell epitope P30 enhances HER2/neu-engineered dendritic cell-induced immunity against Tg1-1 breast cancer in transgenic FVBneuN mice by enhanced CD4+ T-cell-stimulated CTL responses." Cancer Gene Therapy 20.10 (2013): 590-598. DOI:10.1038/cgt.2013.60 |
|
|